Literature DB >> 24860767

Pemphigus vulgaris: A dermatological sequel of severe H1N1 infection.

Preema Sinha1, Manas Chatterjee1, Biju Vasudevan1.   

Abstract

Entities:  

Year:  2014        PMID: 24860767      PMCID: PMC4030360          DOI: 10.4103/2229-5178.131131

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


× No keyword cloud information.
Sir, Pemphigus vulgaris (PV) is an autoimmune disease characterized by blistering involving the skin and mucosa that develops due to interaction between predisposing genetic and environmental factors. Various infectious agents such as viruses of the Herpesviridae family have been implicated as stimulants of the immune system that eventually trigger PV. There have been no reports linking H1N1 infection to PV in the literature. Herein we report the case of a 50-year-old man who developed extensive PV within 15 days of recovering from life-threatening H1N1 infection. A 50-year-old man presented with multiple fluid filled lesions all over the body and oral ulcers of 15 days duration. Onset was insidious with appearance of multiple lesions initially over legs, which ruptured easily leaving behind red, raw areas. Lesions progressively increased in size and number over the next 2-3 weeks to involve trunk and extremities and were associated with oozing of odorless, serous fluid and mild pain. Crusting was noted after two weeks. There was a history of erosions in the oral cavity which healed within one week. There was no history of fever, constitutional symptoms, dysphagia, hoarseness of voice, ocular or genital ulcers, photosensitivity, or significant weight loss. He had been admitted to a tertiary care hospital 15 days prior to onset of skin lesions with cough and breathlessness. Investigations that included nasopharyngeal swab for real-time polymerase chain reaction confirmed H1N1 infection. He was managed with mechanical ventilation: lung protective ventilation with optimal positive end-expiratory pressure along with dual antivirals (oseltamivir with zanamivir) for 7 days, parenteral antibiotics (teicoplanin and meropenem), and supportive care. Dermatological examination revealed flaccid bullae with clear fluid, erosions, and crusted plaques distributed over trunk, both upper and lower extremities [Figure 1]. The Nikolsky's sign and bulla spread sign were positive. Examination of the oral mucosa, genitalia, palms, and soles was normal at the time of examination.
Figure 1

Multiple flaccid bullae and crusted plaques seen over both feet and back

Multiple flaccid bullae and crusted plaques seen over both feet and back Tzanck smear showed acantholytic cells; histopathological examination revealed acantholysis and loss of intercellular bridges in epidermis. Intraepidermal bullae were present and dermis had focal infiltration by chronic inflammatory cells [Figure 2a]. Direct immunofluorescence (DIF) was positive for intercellular IgG and C3 [Figure 2b]. A diagnosis of PV was made and he was treated with dexamethasone cyclophosphamide pulse therapy with excellent response to treatment. He is presently in remission with no fresh lesions since two years.
Figure 2

Histopathology showing intraepidermal bulla with acantholytic cells (H and E, ×40) and direct immunofluorescence of perilesional skin showing presence of C3 in the intracellular regions of the epidermis

Histopathology showing intraepidermal bulla with acantholytic cells (H and E, ×40) and direct immunofluorescence of perilesional skin showing presence of C3 in the intracellular regions of the epidermis The immunopathogenesis of pemphigus is not fully understood and has been explained on the basis of epitope spreading and molecular mimicry.[1] Infectious agents such as viruses can act in the following ways to trigger pemphigus: They stimulate the immune response in genetically susceptible individuals leading to an increase in production of interferon and interleukins. High levels of interferon-gamma induce the expression of HLA type 2 in the membranes of keratinocytes, making the structural site of PV antigen immunologically active (epitope spreading).[2] Microbes can also direct the release of cytokines and chemokines, whereas viruses can infect and selectively replicate in unique lymphocyte subsets and, by their presence, activation, or replication, cause immunosuppression or immunoenhancement. Another possible mechanism of association between viruses and PV is molecular mimicry, due to sharing of linear or conformational epitopes common to microbial antigens and host structures. This is an immunological phenomenon in which the primary immune response, usually to a pathogenic microorganism, cross-reacts with a self-antigen and causes autoimmune disease.[3] Infectious agents, such as herpes simplex virus, Epstein–Barr virus, cytomegalovirus, and herpes virus 8 have been implicated in various studies as triggers for PV.[4] Thus far, pemphigus and linear IgA bullous dermatosis have been reported after influenza vaccination.[56] However, H1N1 infection or vaccination has not been linked to pemphigus in the literature. Neurological sequelae of H1N1 infection, such as multiple strokes, seizures, and encephalopathy, have been mentioned; however, there is a paucity of reports of dermatological sequelae post-H1N1 infection.[7] Only purpuric skin lesions and post-H1N1 vaccination-related skin lesions, such as erythema, unspecified skin rash, pityriasis rosea, urticaria, angioedema, and vasculitis find a mention in the literature.[89] Drug-induced pemphigus was ruled out in our patient as the drugs administered to him are not known to trigger pemphigus. We therefore propose that the episode of H1N1 infection may have exposed intraepidermal epitopes to the immune system, resulting in the development of anti-intercellular antibodies and PV in our patient. To our knowledge, this is the first report of a case of PV developing soon after a life-threatening episode of H1N1 infection. The H1N1 virus may thus be acting as a trigger for autoimmunity in PV.
  9 in total

Review 1.  Pemphigus and infectious agents.

Authors:  Lior Sagi; Yaniv Sherer; Henri Trau; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2008-08-14       Impact factor: 9.754

2.  Linear IgA bullous dermatosis following influenza vaccination.

Authors:  Lauren Alberta-Wszolek; Alyse M Mousette; Meera Mahalingam; Nikki A Levin
Journal:  Dermatol Online J       Date:  2009-11-15

Review 3.  Refractory pemphigus vulgaris associated with herpes infection: case report and review.

Authors:  Maria Luiza Figueiredo Braga Brandão; Nurimar C Fernandes; Danielle Pereira de Oliveira Batista; Norma Santos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2011 Mar-Apr       Impact factor: 1.846

Review 4.  Viruses in pemphigus: a casual or causal relationship?

Authors:  V Ruocco; R Wolf; E Ruocco; A Baroni
Journal:  Int J Dermatol       Date:  1996-11       Impact factor: 2.736

5.  Pityriasis rosea following influenza (H1N1) vaccination.

Authors:  Jeng-Feng Chen; Chien-Ping Chiang; Yu-Fei Chen; Wei-Ming Wang
Journal:  J Chin Med Assoc       Date:  2011-05-12       Impact factor: 2.743

Review 6.  Epitope spreading: lessons from autoimmune skin diseases.

Authors:  L S Chan; C J Vanderlugt; T Hashimoto; T Nishikawa; J J Zone; M M Black; F Wojnarowska; S R Stevens; M Chen; J A Fairley; D T Woodley; S D Miller; K B Gordon
Journal:  J Invest Dermatol       Date:  1998-02       Impact factor: 8.551

7.  Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic.

Authors:  Sirine A Baltagi; Michael Shoykhet; Kathryn Felmet; Patrick M Kochanek; Michael J Bell
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

8.  Exacerbation of pemphigus after influenza vaccination.

Authors:  C De Simone; G Caldarola; M D'agostino; A Zampetti; P Amerio; C Feliciani
Journal:  Clin Exp Dermatol       Date:  2008-08-02       Impact factor: 3.470

9.  Pandemic 2009 H1N1 virus infection associated with purpuric skin lesions: a case report.

Authors:  Rocco Urso; Nazario Bevilacqua; Marco Gentile; Daniele Biagioli; Francesco Nicola Lauria
Journal:  J Med Case Rep       Date:  2011-04-01
  9 in total
  1 in total

Review 1.  Management of Pemphigus in COVID-19 Pandemic Era; a Review Article.

Authors:  Fahimeh Abdollahimajd; Mohammad Shahidi-Dadras; Reza M Robati; Sahar Dadkhahfar
Journal:  Arch Acad Emerg Med       Date:  2020-04-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.